Đang chuẩn bị liên kết để tải về tài liệu:
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials

Proarrhythmia assessment is one of the major concerns for regulatory bodies and pharmaceutical industry. ICH guidelines recommending preclinical tests have been established in attempt to eliminate the risk of drug-induced arrhythmias. | Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials